PPARG and pulmonary hypertension: In a monocrotaline-induced pulmonary hypertension model, treatment with telmisartan protected endothelial cell function by inducing the expression of PPARγ, promoting the phosphorylation of Akt and eNOS, increasing the production of NO, and improving PPARγ-dependent vascular dilation [69].